COSMO Pharmaceuticals SA (COPN) — Capital Reinvestment Ratio

Latest as of June 2025: 2.92x

COSMO Pharmaceuticals SA (COPN) has a Capital Reinvestment Ratio of 2.92x as of June 2025, meaning it reinvests 3% of its operating cash flow (CHF900.00K) in capital expenditures (CHF2.62 Million). Check COSMO Pharmaceuticals SA (COPN) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.92x
Capex / Operating Cash Flow

Operating Cash Flow

CHF900.00K
CHF

Capital Expenditures

CHF2.62 Million
CHF

Data as of

Jun 2025
Most recent filing

COSMO Pharmaceuticals SA Capital Reinvestment Ratio (2004–2024)

This chart tracks COSMO Pharmaceuticals SA's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see cash flow conversion of COSMO Pharmaceuticals SA.

Annual Capital Reinvestment Ratio for COSMO Pharmaceuticals SA (2004–2024)

Year-by-year Capital Reinvestment Ratio for COSMO Pharmaceuticals SA from 2004 to 2024. See COSMO Pharmaceuticals SA (COPN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CHF) Capital Expenditures YoY Change
2024 0.03x CHF162.41 Million CHF5.65 Million ▼ -82.0%
2023 0.19x CHF22.71 Million CHF4.40 Million ▼ -12.0%
2022 0.22x CHF33.23 Million CHF7.31 Million ▼ -67.4%
2021 0.67x CHF12.61 Million CHF8.50 Million ▲ +8.3%
2020 0.62x CHF12.98 Million CHF8.09 Million ▼ -10.8%
2016 0.70x CHF26.41 Million CHF18.43 Million ▲ +1747.0%
2014 0.04x CHF66.45 Million CHF2.51 Million ▼ -88.8%
2013 0.34x CHF8.11 Million CHF2.73 Million ▲ +154.8%
2012 0.13x CHF23.00 Million CHF3.04 Million ▼ -55.8%
2011 0.30x CHF11.29 Million CHF3.37 Million ▼ -68.7%
2010 0.95x CHF7.79 Million CHF7.42 Million ▼ -45.0%
2009 1.73x CHF3.88 Million CHF6.72 Million ▲ +30.1%
2006 1.33x CHF6.08 Million CHF8.10 Million ▼ -46.1%
2005 2.47x CHF1.70 Million CHF4.20 Million ▼ -73.6%
2004 9.36x CHF261.00K CHF2.44 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow